This is a type of skin cancer that starts in the deepest layer of your skin. It usually grows slowly and rarely spreads to other parts of the body. It's the most common type of skin cancer.
Every report comes from a Lived member, sent anonymously.
Have you had Mohs Surgery for Basal Cell Cancer?
Basal cell cancer, usually called basal cell carcinoma (BCC), is the most common type of skin cancer. It starts in basal cells, the round cells in the lower part of the skin's outer layer. It tends to grow slowly and very rarely spreads to other parts of the body. The danger is local: left alone, it keeps growing wider and deeper and can damage skin, cartilage, bone and nerves, which matters most on the face. Most basal cell cancers appear on sun-exposed skin of the head and neck, such as the nose, ears, eyelids and scalp, but they can form anywhere. The most familiar look is a firm, shiny or pearly bump, sometimes with tiny visible blood vessels or a dip in the center. Others look like a flat red or scaly patch, a pale scar-like area, or a sore that does not heal or heals and then comes back. On lighter skin a growth is often pink or red; on darker skin it is more often brown or black. Many cause no pain, although some bleed easily, crust, itch or feel tender.
Ultraviolet (UV) light is the main cause. UV from the sun or from tanning beds damages the DNA in skin cells, and that damage builds up over many years. Long-term exposure counts, and so do intense bursts, particularly sunburns in childhood. This is why basal cell cancer is most common in older adults and on the parts of the body that see the most sun. Fair skin that burns easily, light eyes and red or blond hair raise the risk, though people of every skin color can develop it. Other risk factors include a previous skin cancer, past radiation treatment to the area, long-term exposure to arsenic, and a weakened immune system, for example from medicines taken after an organ transplant. A small number of people have an inherited condition, most notably basal cell nevus syndrome (also called Gorlin syndrome), that causes many basal cell cancers starting at a young age. Having risk factors does not mean someone did something wrong, and some people develop BCC without any obvious risk factor.
Diagnosis usually starts with a skin exam, often by a dermatologist, who may look at the spot through a lighted magnifier (dermoscopy) to see patterns that help tell basal cell cancer from harmless growths. A look alone cannot confirm it, though. The only way to know is a skin biopsy: after numbing the area, the clinician shaves off or punches out a small sample, or removes the whole spot, and a specialist examines it under a microscope. Results usually come back within days. The biopsy report names the subtype. Together with the tumor's size, its location and whether it has been treated before, the subtype tells the care team how likely the cancer is to grow deeper or come back. Tumors on the nose, eyelids, lips and ears, larger tumors, tumors with poorly defined edges and those that have returned are considered higher risk. After a diagnosis, a full-body skin exam is recommended, because people with one skin cancer are more likely to have others. Scans such as CT or MRI are needed only in uncommon cases where the cancer may have grown into deeper tissue, bone or along a nerve.
The goal is to remove or destroy the whole tumor while keeping as much healthy skin and as good an appearance as possible. Surgery is the most effective option and the usual first choice. In a standard excision, the clinician numbs the area, cuts out the tumor with a margin of normal-looking skin, and a lab checks the edges for remaining cancer. Most basal cell cancers are cured this way, typically in a single office visit. Mohs surgery is a specialized method used for higher-risk tumors, especially on the nose, eyelids, ears and lips, for cancers with unclear borders and for those that have come back. The surgeon removes thin layers one at a time and examines each under the microscope during the visit, stopping once no cancer is seen. It has the highest cure rate and spares the most healthy tissue, but it can take several hours and is not needed for every tumor. For small, low-risk tumors, especially on the trunk, arms or legs, other options can work. Curettage and electrodesiccation scrapes the tumor away and uses heat to destroy remaining cells. Superficial basal cell cancers, which sit only in the top layer of skin, can be treated at home with prescription creams: imiquimod, which stirs up the immune system against the tumor, or fluorouracil (5-FU), a chemotherapy cream. These avoid a surgical cut but cause weeks of redness, crusting and soreness, and their cure rates are lower than surgery's. Photodynamic therapy (a light-sensitizing medicine activated by a special light) and freezing with liquid nitrogen are other options for selected low-risk tumors. Radiation therapy is mainly used for people who cannot have or do not want surgery, often older adults; it works well for many tumors but is less likely to cure than surgery. Rarely, basal cell cancer becomes locally advanced, meaning surgery or radiation can no longer treat it well, or spreads elsewhere. These cases are planned by a team of specialists. Daily pills called hedgehog pathway inhibitors, vismodegib (Erivedge) and sonidegib (Odomzo), block the growth signal that drives most basal cell cancers and shrink tumors in many people, though they often stop working over time. Muscle cramps, hair loss, taste changes, tiredness and weight loss are common and lead many people to pause or stop. These pills can cause severe birth defects, so pregnancy must be ruled out before starting, and effective contraception continues during treatment and for up to about two years afterward; male patients need to use condoms with a partner who is or could become pregnant. When these pills do not work or are not suitable, cemiplimab (Libtayo), an immunotherapy drug, is an approved next option.
For most people, basal cell cancer is found early and cured with one treatment, often a short office procedure. A treated area usually leaves a scar. Scars keep changing for a year or more and most become flatter and less noticeable over time, although tumors on the face may need careful repair, such as a skin flap or graft, to restore appearance. The bigger long-term issue is that new basal cell cancers are common. The same sun-damaged skin can produce more tumors over years or decades, and a treated tumor occasionally returns at the same spot. Regular skin checks are part of life after a diagnosis. A common pattern for a single low-risk tumor is a check around six months after treatment and then yearly, with more frequent visits for people who have had several tumors, a high-risk tumor or an inherited syndrome. Checking your own skin between visits, including the scalp, ears and back with a mirror or a partner's help, makes it easier to catch a new spot while it is small. Sun protection remains worthwhile after diagnosis: shade, protective clothing, a wide-brimmed hat, broad-spectrum sunscreen and avoiding tanning beds reduce further UV damage. People with a weakened immune system or an inherited syndrome usually need closer follow-up and a care team that coordinates skin checks with their other treatment.
Arrange a skin check for any spot or growth that is new, growing, changing, bleeding without a clear reason, or a sore that does not heal or keeps healing and coming back. Early treatment is usually simpler and leaves a smaller scar than treating a tumor that has been allowed to grow. If you have had basal cell cancer, contact the care team that treated you when a new bump, sore or scaly area appears in or near the scar, or when a treated area is not healing as you were told to expect. If you are taking vismodegib or sonidegib and you or your partner may be pregnant, contact the prescriber right away.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Basal Cell Cancer is like, what's helped you, or ask the community a question.